These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16412878)

  • 1. Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
    Patel P; Gonzalez R; Dokainish H; Lakkis N
    J Am Coll Cardiol; 2006 Jan; 47(2):464-5. PubMed ID: 16412878
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting.
    Dalén M; van der Linden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):230-4. PubMed ID: 24447500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation.
    Geisler T; Anders N; Paterok M; Langer H; Stellos K; Lindemann S; Herdeg C; May AE; Gawaz M
    Diabetes Care; 2007 Feb; 30(2):372-4. PubMed ID: 17259513
    [No Abstract]   [Full Text] [Related]  

  • 4. Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.
    Gurbel PA; Bliden KP; Antonino MJ; Gesheff T; Cummings CC; Dubois BV; Herzog WR; Tantry US
    Thromb Res; 2012 Jan; 129(1):1-2. PubMed ID: 21862113
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
    Am J Cardiol; 2006 Jan; 97(1):38-43. PubMed ID: 16377281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel.
    Lordkipanidzé M; Pharand C; Palisaitis DA; Schampaert E; Diodati JG
    Thromb Res; 2009 Nov; 124(5):546-53. PubMed ID: 19419755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting.
    Toma C; Zahr F; Moguilanski D; Grate S; Semaan RW; Lemieux N; Lee JS; Cortese-Hassett A; Mulukutla S; Rao SV; Marroquin OC
    Am J Cardiol; 2012 Apr; 109(8):1148-53. PubMed ID: 22277895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Platelets; 2015; 26(6):545-51. PubMed ID: 25167467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
    Steinhubl S; Roe MT
    Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tailored loading-dose clopidogrel in patients undergoing selected percutaneous coronary intervention based on adenosine diphosphate-mediated platelet aggregation.
    Meng K; Lü SZ; Zhu HG; Chen X; Ge CJ; Song XT
    Chin Med J (Engl); 2010 Dec; 123(24):3578-82. PubMed ID: 22166634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.
    Sibbing D; von Beckerath N; Morath T; Stegherr J; Mehilli J; Sarafoff N; Braun S; Schulz S; Schömig A; Kastrati A
    Eur Heart J; 2010 May; 31(10):1205-11. PubMed ID: 20159881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to letter by Petricevic et al regarding "Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting".
    Dalén M; van derLinden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):e59. PubMed ID: 25262298
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical management of clopidogrel inefficiency by point of care platelet function testing and individual adjustment of anti-platelet therapy--initial experiences.
    Schuhmann CG; Sohn HY; Nagel J; Spannagl M; Klauss V; Krötz F
    Platelets; 2009 Nov; 20(7):498-504. PubMed ID: 19852689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD
    Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatment.
    Kalantzi KI; Dimitriou AA; Goudevenos JA; Tselepis AD
    Platelets; 2012; 23(2):121-31. PubMed ID: 21806493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
    von Beckerath N; Taubert D; Pogatsa-Murray G; Schömig E; Kastrati A; Schömig A
    Circulation; 2005 Nov; 112(19):2946-50. PubMed ID: 16260639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Heart; 2010 Feb; 96(3):186-9. PubMed ID: 19687016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.